Methyclothiazide side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Methyclothiazide. Common side effects include arthralgia among females and anorexia among males.

The phase IV clinical study is created by eHealthMe based on 69 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 16, 2022

69 people who take Methyclothiazide and have side effects are studied.


What is Methyclothiazide?

Methyclothiazide has active ingredients of methyclothiazide. eHealthMe is studying from 72 Methyclothiazide users for its effectiveness, alternative drugs and more.

Number of Methyclothiazide reports submitted per year:

Methyclothiazide side effects.

Methyclothiazide side effects by time on the drug*:

< 1 month:

n/a

1 - 6 months:

  1. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Autoimmune hepatitis
  2. Faeces discoloured
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Abdominal pain upper
  5. Agitation (state of anxiety or nervous excitement)
  6. Antinuclear antibody positive
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  8. Blood glucose increased
  9. Carotid artery stenosis (narrowing of carotid artery)
  10. Cerebellar syndrome (impaired blood circulation to cerebellum due to lesion in artery)

Methyclothiazide side effects by gender *:

female:

  1. Arthralgia (joint pain)
  2. Anaemia (lack of blood)
  3. Angle closure glaucoma (term used for several ocular diseases that ultimately result in increased intraocular pressure (iop) and decreased visual acuity)
  4. Blood glucose decreased
  5. Cellulitis (infection under the skin)
  6. Colon cancer
  7. Faeces discoloured
  8. Abdominal pain upper
  9. Agitation (state of anxiety or nervous excitement)
  10. Antinuclear antibody positive

male:

  1. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  2. Arthralgia (joint pain)
  3. Blood glucose increased
  4. Cough
  5. Drug ineffective
  6. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  7. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Pancreatitis (inflammation of pancreas)

Methyclothiazide side effects by age (0-1 to 60+) *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Angle closure glaucoma (term used for several ocular diseases that ultimately result in increased intraocular pressure (iop) and decreased visual acuity)

40-49:

  1. Arthralgia (joint pain)

50-59:

  1. Constipation
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

60+:

  1. Blood glucose decreased
  2. Cellulitis (infection under the skin)
  3. Drug ineffective
  4. Faeces discoloured
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Abdominal pain upper
  7. Agitation (state of anxiety or nervous excitement)
  8. Antinuclear antibody positive
  9. Arthralgia (joint pain)
  10. Blood glucose increased

* Approximation only. Some reports may have incomplete information.

Do you take Methyclothiazide?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



How the study uses the data?

The study is based on methyclothiazide (the active ingredients of Methyclothiazide) and Methyclothiazide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Methyclothiazide:

All Methyclothiazide side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: